Mutational analysis of the propensity for amyloid formation by a globular protein

被引:208
作者
Chiti, F
Taddei, N
Bucciantini, M
White, P
Ramponi, G
Dobson, CM
机构
[1] Univ Oxford, Oxford Ctr Mol Sci, New Chem Lab, Oxford OX1 3QT, England
[2] Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy
关键词
acylphosphatase; amyloid fibrils; conformational stability; protein engineering; protein misfolding;
D O I
10.1093/emboj/19.7.1441
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acylphosphatase can be converted in vitro, by addition of trifluoroethanol (TFE), into amyloid fibrils of the type observed in a range of human diseases. The propensity to form fibrils has been investigated for a series of mutants of acylphosphatase by monitoring the range of TFE concentrations that result in aggregation. We have found that the tendency to aggregate correlates inversely with the conformational stability of the native state of the protein in the different mutants. In accord with this, the most strongly destabilized acylphosphatase variant forms amyloid fibrils in aqueous solution in the absence of TFE, These results show that the aggregation process that leads to amyloid deposition takes place from an ensemble of denatured conformations under conditions in which non-covalent interactions are still favoured. These results support the hypothesis that the stability of the native state of globular proteins is a major factor preventing the in vivo conversion of natural proteins into amyloid fibrils under non-pathological conditions. They also suggest that stabilizing the native states of amyloidogenic proteins could aid prevention of amyloidotic diseases.
引用
收藏
页码:1441 / 1449
页数:9
相关论文
共 46 条
  • [1] ARCHITECTURE AND POLYMORPHISM OF FIBRILLAR SUPRAMOLECULAR ASSEMBLIES PRODUCED BY IN-VITRO AGGREGATION OF HUMAN CALCITONIN
    BAUER, HH
    AEBI, U
    HANER, M
    HERMANN, R
    MULLER, M
    ARVINTE, T
    MERKLE, HP
    [J]. JOURNAL OF STRUCTURAL BIOLOGY, 1995, 115 (01) : 1 - 15
  • [2] Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid
    Baures, PW
    Oza, VB
    Peterson, SA
    Kelly, JW
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (07) : 1339 - 1347
  • [3] Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
    Booth, DR
    Sunde, M
    Bellotti, V
    Robinson, CV
    Hutchinson, WL
    Fraser, PE
    Hawkins, PN
    Dobson, CM
    Radford, SE
    Blake, CCF
    Pepys, MB
    [J]. NATURE, 1997, 385 (6619) : 787 - 793
  • [4] Thermodynamic stability of wild-type and mutant p53 core domain
    Bullock, AN
    Henckel, J
    DeDecker, BS
    Johnson, CM
    Nikolova, PV
    Proctor, MR
    Lane, DP
    Fersht, AR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) : 14338 - 14342
  • [5] Conformational stability of muscle acylphosphatase: The role of temperature, denaturant concentration, and pH
    Chiti, F
    van Nuland, NAJ
    Taddei, N
    Magherini, F
    Stefani, M
    Ramponi, G
    Dobson, CM
    [J]. BIOCHEMISTRY, 1998, 37 (05) : 1447 - 1455
  • [6] Designing conditions for in vitro formation of amyloid protofilaments and fibrils
    Chiti, F
    Webster, P
    Taddei, N
    Clark, A
    Stefani, M
    Ramponi, G
    Dobson, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 3590 - 3594
  • [7] Chiti F, 1999, NAT STRUCT BIOL, V6, P1005
  • [8] Chiti F, 1999, NAT STRUCT BIOL, V6, P380
  • [9] Structural characterization of the transition state for folding of muscle acylphosphatase
    Chiti, F
    Taddei, N
    van Nuland, NAJ
    Magherini, F
    Stefani, M
    Ramponi, G
    Dobson, CM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1998, 283 (04) : 893 - 903
  • [10] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320